Barbara Burnim Day files SEC Form 4 disclosures for REPLIGEN CORP. They have made 1 open-market trade across 1 company since 2005, most recently 2006-01-24.
CIK 0001241028
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RGEN | 2,000 | $351K |
Shares reported on the most recent Form 4, priced at the 2006-01-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RGEN | SELL | 2005-12-27 | 2006-01-27 | $3.81 | $55K | -17.5% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.